HPLC with Post-Column Derivatization with Alizarin for Determination of OATD-02, an Anticancer Arginase Inhibitor in Clinical Development
-
Published:2023-08-13
Issue:16
Volume:13
Page:9201
-
ISSN:2076-3417
-
Container-title:Applied Sciences
-
language:en
-
Short-container-title:Applied Sciences
Author:
Sobolewska Elzbieta12ORCID, Tyszkiewicz Magdalena2, Blaszczyk Roman2ORCID, Biesaga Magdalena1ORCID
Affiliation:
1. Faculty of Chemistry, University of Warsaw, Pasteur 1 Street, 02-093 Warsaw, Poland 2. Molecure SA, Zwirki i Wigury 101 Street, 02-089 Warsaw, Poland
Abstract
The aim of this study was to develop an analytical method for selective determination of OATD-02 by high-performance liquid chromatography (HPLC) with post-column derivatization and fluorescence detection (FLD). OATD-02, a new boronic acid derivative, is a highly potent anticancer arginase inhibitor in clinical development. Chromatographic analysis of OATD-02 poses problems because this molecule has weak ultraviolet absorption. The derivatization reaction was based on the reaction between boronic acid from OATD-02 and alizarin solution. The optimized mobile phase consisted of a mixture of sodium bicarbonate in water and acetonitrile at a flow rate of 0.50 mL/min. Alizarin solution in methanol was delivered at a flow rate of 0.50 mL/min. The fluorescent complexes were detected by a fluorescence detector (excitation and emission wavelengths at 470 and 580 nm, respectively). The present method demonstrated proper values for selectivity, linearity, recovery (>99%), precision (RSD: 0.6%), sensitivity (LOD: 20 µg/mL and LOQ: 50 µg/mL), stability of solutions, and robustness.
Subject
Fluid Flow and Transfer Processes,Computer Science Applications,Process Chemistry and Technology,General Engineering,Instrumentation,General Materials Science
Reference36 articles.
1. (2023, March 29). ICH Harmonised Guideline, Analytical Procedure Development Q14. Available online: https://database.ich.org/sites/default/files/ICH_Q14_Document_Step2_Guideline_2022_0324.pdf. 2. (2023, March 29). ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1). Available online: https://database.ich.org/sites/default/files/Q2%28R1%29%20Guideline.pdf. 3. Arginase 1/2 inhibitor OATD-02: From discovery to first-in-man setup in cancer immunotherapy;Borek;Mol. Cancer Ther.,2023 4. Grzybowski, M.M., Stańczak, P.S., Pomper, P., Błaszczyk, R., Borek, B., Gzik, A., Nowicka, J., Jędrzejczak, K., Brzezińska, J., and Rejczak, T. (2022). OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer. Cancers, 14. 5. Selective determination of potential impurities in an active pharmaceutical ingredient using HPLC-SPE-HPLC;Yamamoto;J. Pharm. Biomed. Anal.,2013
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|